Privacy Policy

Data protection statement

FGK Clinical Research GmbH thanks you for visiting our website and for your interest in our company.

FGK Clinical Research GmbH fully complies with the Federal Data Protection Act (Bundesdatenschutzgesetz—BDSG); any personal data such as entires that can be used to immediately identify a natural person or make such identification possible will not be collected.

For data protection purposes, this website does not use “cookies” or “Java” applications. This website does however contain links to other websites.

The operator of this website cannot be held liable for the content of linked websites. The operator of this website cannot guarantee that the content displayed on linked websites at any given time is within applicable law.

FGK Clinical Research GmbH dissociates itself from any such content that violates applicable law.

EU General Data Protection Regulation

For information on the EU General Data Protection Regulation [Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) (Text with EEA relevance)] please visit:

Public Index of procedures

Public Processing Directory

In accordance with §4 of the Federal Data Protection Act (Bundesdatenschutzgesetz—BDSG), the company must provide the information outlined in §4e of the BDSG to anyone upon request. In order to comply with this legal obligation to the fullest, we have provided this information below, thus eliminating the need for any written requests.

1 Name of Representive

FGK Clinical Research GmbH
Heimeranstrasse 35
80339 Munich

2 Director(s)
Dr. med. Edgar J. Fenzl
Dipl. Stat. Martin Krauss

3 Address of Representative
Heimeranstrasse 35
80339 Munich

4 Purposes of Collecting, Processing or Using Personal Data

The main focus of this company is scientific and clinical studies, specifically the planning, organizing and supervising of the development and testing of pharmaceuticals, bio-pharmaceuticals and medical products, their computer-based evaluations, the drafting of reports as well as the presentation of the results. Other activities are providing consultation in this area, furnishing professional medical opinion and developing and distributing medical and statistical computer software in relation to this area.

Secondary purposes for collecting, processing or using personal data are for personnel, contractor and client administration.

5 Description of the Groups of Data Subjects and the Appurtenant Data or Categories of Data

In compliance with the purposes stated in #4, the following personal data for the given data subjects is collected, processed and used:

  • Client data (addresses, including E-mail addresses; contract data)
  • Personal data (for employee and externals administration), data from
  • business partners (addresses; contract data)
  • contractor data (addresses, contract data)

6 Recipients or Categories of Recipients to whom the Data may be transferred

  • Public bodies that collect data by law (e.g. social insurance agencies, authorities)
  • Internal bodies that participate in delivering business processes (e.g. human resources, accounting)
  • External bodies that participate in managing business processes (partners participating in the business processes described in #4)
  • External contractors as outlined in §11 of the BDSGCredit institutions (salary payment, payment transactions necessary in the business processes described in #4
  • Company insurances related to retirement benefits

7 Standard Periods for the Erasure of Data

Many storage periods and obligations have been decreed by law. Upon the expiration of these periods, the necessary data is routinely deleted. Data not subject to storage obligations is deleted if it does not serve the purposes described in #4.

8 Planned Data Transfer to Third Party States

The transfer of data to third party states is possible in relation to the purposes described in #4, so long as such a transfer is lawful and necessary to the fulfillment of the purposes described. Accordingly, the agreements set out in §11, §4b or §4c of the BDSG are strictly followed. This applies also to the purposes described in #6.

9. Contact Data Protection Officer

Phone: +49 89 893 119 - 0

The current BDSG in applicable form or other applicable laws are binding in this regard.

FGK Clinical Research GmbH